Safranal inhibits estrogen-deficiency osteoporosis by targeting Sirt1 to interfere with NF-κB acetylation.
Safranal, derived from Saffron, has anti-inflammatory properties. Its role in osteoporosis, a bone disease in menopause, and its effect on osteoclasts regulated by NF-κB signaling is unknown.
- Sheng SR et al (2023).
- Phytomedicine.
- PubMed:
- 37004404